Lynx1 Capital Management LP

Entity
Company
Business address
151 Calle De San Francisco, Suite 200 Pmb 1237, 00901-1607 San Juan, PR
Phone
703-963-7214
State of incorporation
DE
Fiscal year end
December 31
13F signature
Weston Nichols - Chief Investment Officer
13D/G Schedule signature
Lynx1 Capital Management LP - By: Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member
Insider ownership signature
Lynx1 Capital Management LP, By: Lynx1 Capital Management GP LLC, its general partner, By: /s/ Weston Nichols, Sole Member
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Lynx1 Capital Management LP has filed 88 SEC EDGAR filings since 2/14/2022

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13D/A Open Document Open Filing Nov 18, 2025
PREC14A Open Document Open Filing PREC14A Nov 14, 2025
SCHEDULE 13G/A Open Document Open Filing Nov 14, 2025
SCHEDULE 13G/A Open Document Open Filing Nov 14, 2025
SCHEDULE 13G/A Open Document Open Filing Nov 14, 2025
SCHEDULE 13G/A Open Document Open Filing Nov 14, 2025
13F-HR Open Document Open Filing Nov 13, 2025 Sep 30, 2025 028-22151
SCHEDULE 13D/A Open Document Open Filing Nov 10, 2025
4 Open Document Open Filing Oct 30, 2025 Oct 28, 2025 001-39856
SCHEDULE 13D Open Document Open Filing Oct 23, 2025
4 Open Document Open Filing Oct 23, 2025 Oct 21, 2025 001-41157
3 Open Document Open Filing Oct 23, 2025 Oct 21, 2025 001-41157
4 Open Document Open Filing Oct 21, 2025 Oct 14, 2025 001-39856
4 Open Document Open Filing Oct 10, 2025 Oct 8, 2025 001-39856
3 Open Document Open Filing Oct 10, 2025 Oct 8, 2025 001-39856
SCHEDULE 13G/A Open Document Open Filing Oct 10, 2025
4 Open Document Open Filing Sep 15, 2025 Sep 11, 2025 001-39231
N-PX Open Document Open Filing Aug 21, 2025 Jun 30, 2025 028-22151
13F-HR Open Document Open Filing Aug 14, 2025 Jun 30, 2025 028-22151
SCHEDULE 13G/A Open Document Open Filing Aug 14, 2025
SCHEDULE 13G Open Document Open Filing Aug 14, 2025
4 Open Document Open Filing Jul 24, 2025 Jul 22, 2025 001-39231
4 Open Document Open Filing May 21, 2025 May 19, 2025 001-40603
13F-HR Open Document Open Filing May 15, 2025 Mar 31, 2025 028-22151
13F-HR Open Document Open Filing Feb 14, 2025 Dec 31, 2024 028-22151
SCHEDULE 13G Open Document Open Filing Feb 14, 2025
SCHEDULE 13G/A Open Document Open Filing Feb 14, 2025
SCHEDULE 13G Open Document Open Filing Feb 14, 2025
SCHEDULE 13G/A Open Document Open Filing Feb 14, 2025
SCHEDULE 13G/A Open Document Open Filing Feb 10, 2025
SCHEDULE 13G/A Open Document Open Filing Feb 10, 2025
4 Open Document Open Filing Dec 31, 2024 Dec 27, 2024 001-39231
4 Open Document Open Filing Dec 30, 2024 Dec 26, 2024 001-40603
4 Open Document Open Filing Dec 16, 2024 Dec 12, 2024 001-40603
4 Open Document Open Filing Nov 27, 2024 Nov 25, 2024 001-39231
4 Open Document Open Filing Nov 19, 2024 Nov 15, 2024 001-40603
13F-HR Open Document Open Filing Nov 14, 2024 Sep 30, 2024 028-22151
SC 13G/A Open Document Open Filing PIERIS PHARMACEUTICALS, INC. Nov 14, 2024
SC 13G/A Open Document Open Filing GH RESEARCH PLC Nov 14, 2024
SC 13G/A Open Document Open Filing BIONOMICS LIMITED Nov 14, 2024
SC 13G/A Open Document Open Filing C4 THERAPEUTICS, INC. Nov 14, 2024
SC 13G/A Open Document Open Filing STOKE THERAPEUTICS, INC. Nov 14, 2024
N-PX Open Document Open Filing Oct 10, 2024 Jun 30, 2024 028-22151
13F-HR/A Open Document Open Filing Aug 19, 2024 Jun 30, 2024 028-22151
13F-HR Open Document Open Filing Aug 14, 2024 Jun 30, 2024 028-22151
SC 13G/A Open Document Open Filing PASSAGE BIO, INC. Aug 9, 2024
3 Open Document Open Filing Aug 9, 2024 Aug 7, 2024 001-39231
13F-HR/A Open Document Open Filing May 30, 2024 Mar 31, 2024 028-22151
13F-HR Open Document Open Filing May 15, 2024 Mar 31, 2024 028-22151
4 Open Document Open Filing Apr 23, 2024 Apr 19, 2024 001-40603
SC 13G Open Document Open Filing IBIO, INC. Apr 1, 2024
SC 13G Open Document Open Filing PASSAGE BIO, INC. Mar 29, 2024
SC 13G Open Document Open Filing GH RESEARCH PLC Feb 16, 2024
13F-HR Open Document Open Filing Feb 14, 2024 Dec 31, 2023 028-22151
SC 13G/A Open Document Open Filing ALPINE IMMUNE SCIENCES, INC. Feb 14, 2024
SC 13G/A Open Document Open Filing KINNATE BIOPHARMA INC. Feb 14, 2024
SC 13G/A Open Document Open Filing PASSAGE BIO, INC. Feb 14, 2024
SC 13G/A Open Document Open Filing C4 THERAPEUTICS, INC. Feb 14, 2024
SC 13G/A Open Document Open Filing STOKE THERAPEUTICS, INC. Feb 14, 2024
SC 13G/A Open Document Open Filing CABALETTA BIO, INC. Feb 14, 2024
SC 13G/A Open Document Open Filing PIERIS PHARMACEUTICALS, INC. Feb 14, 2024
SC 13G/A Open Document Open Filing NEUROGENE INC. Feb 14, 2024
SC 13G/A Open Document Open Filing BIONOMICS LIMITED Feb 14, 2024
13F-HR Open Document Open Filing Nov 14, 2023 Sep 30, 2023 028-22151
SC 13G Open Document Open Filing C4 THERAPEUTICS, INC. Nov 13, 2023
SC 13G Open Document Open Filing STOKE THERAPEUTICS, INC. Nov 6, 2023
SC 13G Open Document Open Filing BIONOMICS LIMITED Oct 30, 2023
13F-HR Open Document Open Filing Aug 14, 2023 Jun 30, 2023 028-22151
4 Open Document Open Filing Jun 2, 2023 May 31, 2023 001-40603
3 Open Document Open Filing Jun 2, 2023 May 31, 2023 001-40603
SC 13G Open Document Open Filing TSCAN THERAPEUTICS, INC.. Jun 2, 2023
13F-HR Open Document Open Filing May 15, 2023 Mar 31, 2023 028-22151
SC 13G/A Open Document Open Filing CABALETTA BIO, INC. Feb 14, 2023
SC 13G/A Open Document Open Filing PASSAGE BIO, INC. Feb 14, 2023
SC 13G/A Open Document Open Filing PIERIS PHARMACEUTICALS, INC. Feb 14, 2023
SC 13G/A Open Document Open Filing ALPINE IMMUNE SCIENCES, INC. Feb 14, 2023
13F-HR Open Document Open Filing Feb 14, 2023 Dec 31, 2022 028-22151
SC 13G Open Document Open Filing KINNATE BIOPHARMA INC. Jan 23, 2023
SC 13G Open Document Open Filing PARDES BIOSCIENCES, INC. Jan 23, 2023
SC 13G Open Document Open Filing NEOLEUKIN THERAPEUTICS, INC. Dec 30, 2022
13F-HR Open Document Open Filing Nov 14, 2022 Sep 30, 2022 028-22151
SC 13G Open Document Open Filing CABALETTA BIO, INC Oct 31, 2022
SC 13G Open Document Open Filing PIERIS PHARMACEUTICALS, INC. Oct 24, 2022
SC 13G Open Document Open Filing PASSAGE BIO, INC. Sep 29, 2022
13F-HR Open Document Open Filing Aug 15, 2022 Jun 30, 2022 028-22151
13F-HR Open Document Open Filing May 16, 2022 Mar 31, 2022 028-22151
SC 13G Open Document Open Filing ALPINE IMMUNE SCIENCES, INC. Apr 22, 2022
13F-HR Open Document Open Filing Feb 14, 2022 Dec 31, 2021 028-22151